IVERMECTIN

JDD October 2023 Issue Highlights | Special Topic: Atopic Dermatitis
182121821218212atopic dermatitisThe October 2023 issue of the Journal of Drugs in Dermatology (JDD) focuses on atopic dermatitis and features mix of original articles, letters to the editor, and case reports. Among many of the topics explored in this issue are statins for treating actinic porokeratosis, ant venom-based ceramide therapy, the psychosocial burden of skin disease among skin of color consumers, treatment of lichen pl …
atopic dermatitis
Rosacea in Diverse Skin Tones | Recognition, Diagnosis, and Treatment
166541665416654We have probably all seen a patient with rosacea. After all, it is quite common in middle-aged, fair-skinned women. Here, however, we will explore a talk given by Dr. Hilary Baldwin (Medical director of the Acne Treatment & Research Center in Morristown, NJ and Brooklyn, NY, and Clinical Associate Professor of Dermatology at Rutgers Robert Wood Johnson Medical Center) at the 2022 Skin of Color …
JDD August Issue Highlights | Special Focus: Psoriasis
163041630416304psoriasisThe August issue of the Journal of Drugs in Dermatology (JDD) focuses on Psoriasis and features mix of original articles, editorials, and case reports. Among many of the topics explored in this issue are treatment of scalp psoriasis, nail psoriasis, respiratory tract infections in patients using biologics for hidradenitis suppurativa, classification of actinic keratosis, lichen planus pigmentosus …
psoriasis
What’s New in Rosacea in 2022
149221492214922rosaceaNext Steps in Derm, in partnership with ODAC Dermatology, Aesthetic and Surgical Conference, interviewed Dr. Neal Bhatia (board-certified Dermatologist who serves as Director of Clinical Dermatology at Therapeutics Clinical Research ) about exciting new developments in rosacea medications. Watch as he offers his most important advice for treating patients with this chronic skin condition. � …
rosacea
Pruritis Rash – Friday Pop Quiz 11/12
143811438114381 This patient presents with an intensely pruritis rash. KOH examination is negative. She denies any recent travel, however does take her 2 year old to the local playground where there is a sandbox. Which of the following is most appropriate? A. This is likely a dermatophyte despite a negative KOH. Treat with topical antifungals B. Inform the patient she is contagious and should isolate he …